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Abstract: 
 
Parkinson's disease is a neurodegenerative disease, which is the most 
common neurodegenerative disorder associated with age after Alzheimer. 
The disease is caused by the loss of dopaminergic neurons of the midbrain 
and subsequent reduction of dopamine in the striatum. The pathophysiology 
of Parkinson's disease has not been clearly identified, but it has been shown 
that oxidative stress plays an important role in it. Hydrogen Sulfide (H2S) is 
an endogenous gas neurotransmitter that has been shown to have 
neuroprotective effects. In this study, the effect of pretreatment with 
hydrogen sulfide on the creation and severity of Parkinson's disease in the 6-
hydroxy-dopamine (6-OHDA) animal model is studied. To investigate the 
hydrogen sulfide neuroprotective mechanism, malondialdehyde level 
(MDA), as an important indicator of oxidative stress, is checked in the brain's 
substantia nigra core. The 6-OHDA toxin was injected into the middle 
cerebral area of the frontal brain by a stereotaxic surgery. Sodium hydrogen 
sulfide (NaHS) was given as a hydrogen sulfide feeder from an hour before 
the toxin injection to 7 days later, daily with doses of 3 and 5.6 mg per kg of 
body weight. In the third and fifth week after surgery, apomorphine-induced 
rotational-behavioral tests were performed and the animal's body circling 
was made. In the seventh week after brain surgery, the animals were 
extracted and the midbrain area was isolated and homogenized. The 
concentration of MDA in homogenized supernatant created was measured 
using a special kit. The apomorphine-induced rotation test showed that 
treatment with NaHS caused a significant decrease in the number and 
severity of rotations. Treatment with NaHS also significantly reduced the 
deviations of the circling toward the damage hemisphere in the mice 
receiving the toxin. The effect of both doses of NaHS was almost the same 
and did not have a significant difference. Measurement of midbrain 
malondialdehyde level showed that treatment with NaHS significantly 
decreased MDA concentration. Our results indicate that hydrogen sulfide has 
significant anti-Parkinsonian effects, mediated by reducing the level of 
malondialdehyde and oxidative stress. 
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